Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid Tumors.

Rosen, Ezra Y; Schram, Alison M; Young, Robert J; Schreyer, Mark W; Hechtman, Jaclyn F; Shu, Catherine A; Ku, Nora C; Hyman, David M; Drilon, Alexander

Rosen, Ezra Y; Schram, Alison M; Young, Robert J; Schreyer, Mark W; Hechtman, Jaclyn F; Shu, Catherine A; Ku, Nora C; Hyman, David M; Drilon, Alexander.

Afiliação

Rosen EY; Memorial Sloan Kettering Cancer Center, New York, NY.
Schram AM; Memorial Sloan Kettering Cancer Center, New York, NY.
Young RJ; Weill Cornell Medical College, New York, NY.
Schreyer MW; Memorial Sloan Kettering Cancer Center, New York, NY.
Hechtman JF; Memorial Sloan Kettering Cancer Center, New York, NY.
Shu CA; Memorial Sloan Kettering Cancer Center, New York, NY.
Ku NC; Columbia University, New York, NY.
Hyman DM; Loxo Oncology, Stamford, CT.
Drilon A; Memorial Sloan Kettering Cancer Center, New York, NY.

JCO Precis Oncol ; 32019.

Article em En | MEDLINE | ID: mdl-32914009

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article